Myriad Genetics Receives Patent for High-Definition MRD Assay
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.
Read MorePosted by Andy Lundin | Mar 22, 2024 | Unknown Origin & Other Cancer Types |
The U.S. Patent and Trademark Office issued a patent to Myriad Genetics aimed at strengthening its ability to deliver a MRD assay to market.
Read MorePosted by Andy Lundin | Mar 20, 2024 | Molecular Diagnostics |
The collaboration aims to help identify patients who may benefit from precision cancer therapies by offering decentralized genomic testing.
Read MorePosted by Chris Wolski | Mar 20, 2024 | Molecular Diagnostics |
Sherlock Bio is making its proprietary AI platform freely available to anyone interested in developing diagnostics assays.
Read MorePosted by Chris Wolski | Mar 15, 2024 | Miscellaneous |
Data shows how computational indexing combined with a systematic literature review can be used to characterize gene-disease relationships.
Read MorePosted by Andy Lundin | Mar 15, 2024 | Hematology Instrumentation, Lab Automation |
The hematology automation system aims to transform the capabilities of the hospital and facilitate the measurement of complete blood counts.
Read More